Article Text

other Versions

PDF
Infarct size and left ventricular function in the Proximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study
  1. Joost D E Haeck1,*,
  2. Wichert J Kuijt1,
  3. Karel T Koch1,
  4. Luc Bilodeau2,
  5. José P S Henriques1,
  6. Wim J Rohling1,
  7. Jan Baan, Jr1,
  8. Marije M Vis1,
  9. Robin Nijveldt1,
  10. Nan Van Geloven1,
  11. Maarten Groenink1,
  12. Jan J Piek1,
  13. Jan G P Tijssen1,
  14. Mitchell W Krucoff3,
  15. Robbert J De Winter1
  1. 1 Academic Medical Center - University of Amsterdam, Netherlands;
  2. 2 Institut de Cardiology de Montréal, Netherlands;
  3. 3 Duke Clinical Research Institute - Duke University Medical Center, Netherlands
  1. Correspondence to: Joost D.E. Haeck, Cardiology, Academic Medical Center - University of Amsterdam, Meibergdreef 9, Amsterdam, 1100 DD, Netherlands; j.d.haeck{at}amc.uva.nl

Abstract

Objectives: The aim of the study was to evaluate whether primary percutaneous coronary intervention (PCI) with combined proximal embolic protection and thrombus aspiration results in smaller final infarct size (IS) and improved left ventricular function (LVF) assessed by cardiovascular magnetic resonance (CMR) in ST-segment elevation myocardial infarction (STEMI) patients compared with primary PCI alone.

Background: Primary PCI with the Proxis system (St. Jude Medical, St Paul, MN, USA) improves immediate microvascular flow post-procedure as measured by ST-segment resolution which could result in better outcomes.

Methods: The ancillary CMR study included 206 STEMI patients who were enrolled in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation (PREPARE) trial. CMR imaging was assessed between 4 and 6 months after index procedure.

Results: There were no significant differences in final IS (6.1g/m2 vs. 6.3 g/m2, p = 0.78) and LVEF (50 % vs. 50%, p = 0.46) between both groups. Also, systolic wall thickening in infarct area (44% vs. 45%, p = 0.93) or extent of transmural segments (8.3% of segments vs. 8.3% of segments, p = 0.60) showed no significant differences. The incidence of major adverse cardiac and cerebral events (MACCE) at 6 months was similar in the Proxis and control group (8% vs. 10%, respectively, P = 0.43).

Conclusions: Primary PCI with combined proximal embolic protection and thrombus aspiration in STEMI patients did not result in significant differences in final IS or LVF at follow-up CMR. In addition, there was no difference in the incidence of MACCE at 6 months.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.